Psychopharmref

Psychopharmref

Psychopharmacology and psychiatry

Generic availability, a drug-class comparison, and a discovery origin story

Jul 31, 2026

•

5 min read

Generic availability, a drug-class comparison, and a discovery origin story

Where the supply chain stands, how two agents compare head-to-head, and the serendipitous path that brought a drug class to market.

Jerad Shoemaker MD
Jerad Shoemaker MD
Newly Approved Medications

Jul 24, 2026

•

5 min read

Newly Approved Medications

July 23rd, 2026 newsletter

Jerad Shoemaker MD
Jerad Shoemaker MD
Psychiatric pipeline, adverse-event profiles, and how psychiatric science works

Jul 17, 2026

•

6 min read

Psychiatric pipeline, adverse-event profiles, and how psychiatric science works

Compounds nearing approval, a close look at tolerability data, and the methodology shaping psychiatric evidence.

Jerad Shoemaker MD
Jerad Shoemaker MD
Policy & FDA Watch

Jul 11, 2026

•

5 min read

Policy & FDA Watch

CMS Medicaid frailty exemption now requires psychiatric documentation

Jerad Shoemaker MD
Jerad Shoemaker MD
Generic availability, adverse-effect profiles, and diagnostic history

Jul 3, 2026

•

6 min read

Generic availability, adverse-effect profiles, and diagnostic history

Generic availability, adverse-effect profiles, and diagnostic history

Jerad Shoemaker MD
Jerad Shoemaker MD
Candidates advancing through trials, how two treatments compare on evidence, and the legal milestones that shaped prescribing today.

Jun 26, 2026

•

5 min read

Candidates advancing through trials, how two treatments compare on evidence, and the legal milestones that shaped prescribing today.

Pipeline drugs, a head-to-head comparison, and the legal past behind it

Jerad Shoemaker MD
Jerad Shoemaker MD
Load more